| http://www.w3.org/ns/prov#value | - es showed that between 1998 and 2003 there was a small, clinically insignificant increase in the rate of glucose (but not lipid) screening.13 Further, among patients requiring treatment with a second-generation antipsychotic medication, baseline glucose levels were estimated in 19%, lipids in 6%, and both in 5%.13 Predictors of receiving screening included service location, ethnicity, sex, pre-exi
|
